News & Events

HUNG THINH CORPORATION DONATES VND 1 BILLION TO COVID-19 DRUG RESEARCH PROGRAM OF THONG NHAT HOSPITAL

Hung Thinh News |

02-09-2021

In order to join hands to anti-epidemic and protection of people's health, Hung Thinh Corporation donated VND 1 billion to Covid-19 drug research program of Thong Nhat Hospital on September 2, 2021 morning.

Overview of the ceremony of receiving the donation to Covid-19 drug research program of Thong Nhat Hospital

The ceremony of receiving the donation to Covid-19 drug research program of Thong Nhat Hospital was attended by Assoc. Prof. PhD. Dr. Le Dinh Thanh, Director of the hospital; PhD. Dr. Vo Thanh Toan, Deputy Director of the hospital. On the side of Hung Thinh Corporation, the ceremony was attended by Mr. Truong Van Viet, Vice Chairman cum Deputy General Director of the Corporation; Mr. Le Hong Viet, Vice Chairman cum Deputy General Director of the Corporation and Mr. Huynh Thanh Tu, Deputy General Director of Hung Thinh Incons.

Speaking at the ceremony, Assoc. Prof. PhD. Dr. Le Dinh Thanh, Director of Thong Nhat Hospital shared: “The Covid-19 drug research program of Thong Nhat Hospital is a research project to help promote emergency measures, improve efficiency in treatment and support recovery for patients infected with Covid-19, contribute to preventing from the spread of the epidemic. Our hospital today receives a gift of great material and spiritual significance from Hung Thinh Corporation. With this funding, we will have more resources to research and quickly bring positive results to help improve treatment regimens for Covid-19 patients.”

Assoc. Prof. PhD. Dr. Le Dinh Thanh, Director of Thong Nhat Hospital (second from the left) shared at the ceremony

Mr. Truong Van Viet, Vice Chairman and Deputy General Director of Hung Thinh Corporation (second from the right) and Mr. Le Hong Viet, Vice Chairman and Deputy General Director of Hung Thinh Corporation (rightmost) donated VND 1 billion to Covid-19 drug research program of Thong Nhat Hospital

Also at the ceremony, Mr. Le Hong Viet, Vice Chairman and Deputy General Director of Hung Thinh Corporation said: “In response to the complicated situation of the epidemic, in addition to joint activities to support the community, Hung Thinh Corporation desires to empower the medical team and experts in researching measures to treat and prevent from Covid-19. Hopefully, the companionship with Thong Nhat Hospital in the Covid-19 drug research program will soon bring positive results."

Mr. Le Hong Viet, Vice Chairman and Deputy General Director of Hung Thinh Corporation spoke at the ceremony

Assoc. Prof. PhD.Dr. Le Dinh Thanh, Director of Thong Nhat Hospital (second from the left) and PhD. Dr. Vo Thanh Toan, Deputy Director of Thong Nhat Hospital (leftmost) presented thank you letter to the representative of Hung Thinh Corporation

Thong Nhat Hospital is one of two hospitals in Ho Chi Minh City assigned by the Ministry of Health to research, test and evaluate at medical facilities the drug named Molnupiravir - one of the antiviral drugs that helps quickly reduce the virus concentration in the body of infected people. This is a product researched and developed by two pharmaceutical companies Merck and Ridgeback Biotherapeutics of the US. The drug has been clinically tested at Thong Nhat Hospital and showed positive results.

Immediately after the ceremony, two Parties visited the campus of Thong Nhat Hospital and discussed about accompanying each other in many fields in the near future.

Representatives of Hung Thinh Corporation and representatives of Thong Nhat Hospital visited the hospital's campus

Hung Thinh Corporation hopes that in the coming time, two sides will accompany each other in many fields

The program continues to extend the series of meaningful activities to join hands to support the community for repelling the epidemic of Hung Thinh Corporation for the past time.

Other News